VIGIL NEUROSCIENCE INC's ticker is and the CUSIP is 92673K108. A total of 46 filers reported holding VIGIL NEUROSCIENCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,524,836 | -42.9% | 1,767,131 | -0.4% | 0.37% | -52.3% |
| Q2 2023 | $16,670,045 | -15.9% | 1,773,409 | -12.4% | 0.77% | -5.2% |
| Q1 2023 | $19,826,091 | -24.6% | 2,025,137 | -3.8% | 0.81% | -26.3% |
| Q4 2022 | $26,302,175 | +22.3% | 2,104,174 | -11.0% | 1.10% | +12.1% |
| Q3 2022 | $21,505,000 | +2601.6% | 2,363,188 | +666.3% | 0.98% | +1794.2% |
| Q2 2022 | $796,000 | -70.9% | 308,393 | -20.8% | 0.05% | -70.3% |
| Q1 2022 | $2,736,000 | – | 389,141 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 4,214,498 | $22,716,144 | 65.40% |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $31,460,750 | 4.87% |
| Trustees of Columbia University in the City of New York | 192,973 | $1,040,124 | 1.91% |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $3,021,607 | 1.20% |
| Artal Group S.A. | 1,908,135 | $10,285 | 0.44% |
| Deep Track Capital, LP | 1,767,131 | $9,524,836 | 0.37% |
| DAFNA Capital Management LLC | 172,308 | $928,740 | 0.29% |
| BVF INC/IL | 1,813,633 | $9,775,482 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,827,400 | $9,849,686 | 0.22% |
| Cormorant Asset Management, LP | 616,786 | $3,324,477 | 0.19% |